Company / Book Value per Share
NovoCure Ltd Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.137
FY2025
5-year range
$3.137 / $4.243
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
#133 of 163
Health Care
What the data says
NovoCure Ltd's book value per share of $3.137 is lower than 82% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $4.243 in FY2022 to $3.137 in FY2025.
Based on SEC 10-K filings.
$3.137 in FY2025 with a 5-year CAGR of -8.1%.
Declined from $3.451 to $3.137 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -9.6%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 163This company $3.137 Sector average $47.415
▼
-93.4% below sector average
Key checks
Key Insights
- NovoCure Ltd's book value per share has declined for 3 consecutive years.
- 5-year CAGR of -8.1%, indicating a declining trend.
- In FY2025, book value per share decreased 6.7% year-over-year.
- Ranks #133 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.137 | -6.7% |
| FY2024 | $3.364 | -2.5% |
| FY2023 | $3.451 | -18.7% |
| FY2022 | $4.243 | +5.8% |
| FY2021 | $4.011 | -16.2% |
| FY2020 | $4.788 | +105.0% |
| FY2019 | $2.335 | +86.2% |
| FY2018 | $1.255 | -3.8% |
| FY2017 | $1.304 | -23.2% |
| FY2016 | $1.699 | -90.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026